Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System

• المؤلفون الرئيسيون: Elena Mirabela Velișcu (مؤلف), Valerio Liguori (مؤلف), Antonietta Anatriello (مؤلف), Giorgia Teresa Maniscalco (مؤلف), Andrea Cantone (مؤلف), Luigi Di Costanzo (مؤلف), Pasquale Stefanelli (مؤلف), Cristina Scavone (مؤلف), Annalisa Capuano (مؤلف)
• التنسيق: كتاب
• منشور في: MDPI AG, 2023-07-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background. Cladribine belongs to the group of disease-modifying therapies (DMTs) used to treat multiple sclerosis (MS). According to the highlights of a meeting held by the Pharmacovigilance Risk Assessment Committee (PRAC) on 14 January 2022, cladribine may be associated with the occurrence of liv...